Print
 Pharmacovigilance Guidance Document for Marketing Authorization Holders of Pharmaceutical Products
  7th International Conference of ISPOR India 
  List of ADR Monitoring Centres under Pharmacovigilance Programme of India (1105KB,  ) 
  Orders & Circulars
  Drug Safety Alerts
  PvPI Performance Report  
  MoU between IPC,NCC-PvPI and NABH
  WHO Appreciation Letter to MoHFW for successful National Regulatory Authority(NRA) Assessment (165KB,  ) 
  Office order for submission of Source Documents (343KB,  ) 
  Minutes of Meeting on "4th Interactive Session on Participation of marketing Authorization Holders(MAHs) in PvPI" (709KB,  ) 
  ADRs Reporting Status of AMCs
  Stakeholder Feedback form (71KB,  ) 
  PvPI Newsletters 
  Regulatory Actions
  Monthly Progress Report (PvPI)
  PvPI recommendations to Regulators
  Letter of Intent (350KB,  ) 
  Adverse Drug Reaction Reporting Form for Healthcare Professionals Version-1.3 (616KB,  ) 
  PvPI-Frequently asked questions
  Union Health Minister inaugurated the 38th Annual Meeting of Representatives of National                         
    Pharmacovigilance Centres participating in the WHO Programme for International Drug Monitoring
  PvPI-Frequently asked questions
 Guidance Document for spontaneous Adverse Drug Reaction Reporting (5409KB,  ) 
  Partners Roles and Responsibilities in Ensuring Vaccines Safety (1187KB,  ) 
  Serious AEFI Case notification form (558KB,  )